# BRazilian Asthmatics Patients EOSinophilic Profile (BRAEOS)

> **NCT03925415** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 414 (actual)

## Conditions studied

- Severe Asthma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03925415
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-24
- **Primary completion:** 2019-10-15
- **Final completion:** 2019-10-15
- **Target enrollment:** 414 (ACTUAL)
- **Last updated:** 2020-08-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03925415

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03925415, "BRazilian Asthmatics Patients EOSinophilic Profile (BRAEOS)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03925415. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*